SAN DIEGO, California ― For patients with moderate to severe rheumatoid arthritis whose condition is refractory to methotrexate, pain relief is better with the JAK inhibitor baricitinib than with the ...

Please provide your email address to receive an email when new articles are posted on . Within the baricitinib group, patients experienced a mean Vitiligo Area Scoring Index score change of 44.8% from ...

The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset type 1 diabetes, 2-year data from the phase II BANDIT trial showed. After ...

Baricitinib can effectively treat polymyalgia rheumatica (PMR) without the use of oral glucocorticoids, according to results from a small, randomized, double-blind, placebo-controlled study. Among the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Baricitinib preserved C-peptide levels and lowered ...